Philadelphia, PA - The Castleman Disease Collaborative Network (CDCN) continued to take an innovative approach to advancing research and care for Castleman disease through advocacy-industry-academia partnerships and global physician engagement. On February 27-28, 2015, the CDCN co-hosted the first-ever International Castleman Disease Pathology Preceptorship at the University of Pennsylvania. The Preceptorship included the eight top hematopathologists from across Latin America and the faculty included Drs. David Fajgenbaum, Dale Frank, and Adam Bagg from from the University of Pennsylvania as well as Dr. Ahmet Dogan from Memorial Sloan Kettering Cancer Center.
Check out a news clip from the meeting on 6abc by clicking here.
The two-day gathering focused on:
- an overview of Castleman disease and related inflammatory and malignant disorders,
- a review of diagnostic features found in Castleman disease, and
- case reviews from University of Pennsylvania, Memorial Sloan Kettering Cancer Center, and the eight medical centers in Latin America represented by the attendees.
The event was yet another collaborative partnership forged between the Castleman Disease Collaborative Network, Janssen Pharmaceuticals, and an academic medical center.
About the Castleman Disease Collaborative Network:
The Castleman Disease Collaborative Network (CDCN) is a global research network dedicated to accelerating research and treatment for Castleman disease (CD)—a deadly, hyperinflammatory disease—through global collaboration, investments in high-impact research, strategic partnerships, and patient engagement. Led by a team of physicians, researchers, patients, and their loved ones, the CDCN has made tremendous progress for CD by taking an innovative approach. For more information, go to www.castlemannetwork.org
About the Faculty:
Ahmet Dogan, MD, PhD is the Chief of Hematopathology Section in the Departments of Pathology and Laboratory Medicine at Memorial Sloan Kettering Cancer Center. David Fajgenbaum, MD, MSc is the Co-founder & Executive Director of the Castleman Disease Collaborative Network (CDCN) and an Adjunct Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Pennsylvania. Adam Bagg, MD is Professor of Pathology and Laboratory Medicine and Interim Director of Hematopathology at the University of Pennsylvania. Dale Frank, MD is Assistant Professor of Clinical Pathology and Laboratory Medicine at the University of Pennsylvania.